Note that some links may require registration or subscription.
Los Angeles County, the epicenter of the COVID-19 crisis in California, is facing alarming increases in hospitalizations that could overwhelm the system in the coming weeks. (Los Angeles Times)
And on the Southern border, coronavirus patients from Mexico are flooding emergency rooms in California, though its mostly Americans. (CNN)
Mexico, meanwhile, has received less attention than countries like the U.S. and Brazil during the pandemic, yet its per capita death rate is higher than both, likely because people are becoming too ill before they seek help. (Axios)
As of 8 a.m. ET on Tuesday, the unofficial tally of U.S. COVID-19 cases reached 2,682,897, with 129,544 deaths.
New FDA guidance for COVID-19 vaccine approval states that a candidate must be at least 50% better than placebo. (Wall Street Journal)
The World Health Organization will send a team to China to investigate the origins of the virus. (Reuters)
After scrutiny from regulators, a global COVID-19 prevention trial of hydroxychloroquine will resume. (Reuters)
Lopinavir-ritonavir (Kaletra), an antiviral used for HIV, again showed no benefit in hospitalized COVID-19 patients, according to preliminary findings from the RECOVERY trial.
States continue to reverse course on reopenings: In Arizona, Gov. Doug Ducey (R) said opening up bars again was a mistake and shut them down for the next 30 days, while New Jersey indefinitely paused its plans for indoor dining. (Tuscon.com, CNBC)
Ahead of the Republican National Convention, residents in Jacksonville, Florida will be required to wear masks indoors, but officials in Houston, Texas are not planning to do the same for the state’s GOP convention next month. (Politico, Houston Chronicle)
More and more Republicans are publicly splitting with President Trump on mask-wearing, including U.S. Senate Majority Leader Mitch McConnell who encouraged everyone to wear one. (Reuters)
Scientists are still puzzling over a genetic mutation of the novel coronavirus associated with the outbreaks in Europe and New York. (Washington Post)
More than 200 drugs, including steroids and treatments for cancer and mental health, have seen price jumps since the virus touched down in the U.S. (The Hill)
While one Texan lucked out with a $199 bill for a COVID-19 test, his friend was charged over $6,000 and an essential worker in California was left nearly $2,000 in debt after trying to get tested. (New York Times, NPR)
STAT takes a look at what the U.S. can learn from Taiwan’s COVID-19 response.
In other news:
Source: MedicalNewsToday.com
